QuickView for TAKL%3Bjsessionid%3D40E22499564EAE7F71FA29AA19705F76%3Bjsessionid%3D787005E39F3AFF5E382EC41A340AB170%3Bjsessionid%3D31FD067A41084A84C97BE51309D7990D%3Bjsessionid%3D239C40B3727C3880B4DD59FDA993EB74%3Bjsessionid%3D12274BD3F00DF96945107322433EFB2D%3Bjsessionid%3DBABECBC0925C4C2EF20C533A8061A2D4%3Bjsessionid%3DA9667723F46F28605F09734A99CA4DA2%3Bjsessionid%3D6961CF836CF5728373E2183EADAB2533%3Bjsessionid%3D2895DFEDBF1325C8CD2C502532774450%3Bjsessionid%3D33C9460D4831AA6D3B7A709D82A8F842%3Bjsessionid%3D8D5BA59B60A1709E6B5F9C101B9EFDE3%3Bjsessionid%3D93580840AC4C429D04BD3F6F2436BB77%3Bjsessionid%3D73ED03EBAC438FBFCD9D44ACDC1CF6AE%3Bjsessionid%3DBB88F5D00D84261CFCDA4ED646098553%3Bjsessionid%3DE4F287F641347C3F3A57A0D97BA895FF (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL%3Bjsessionid%3D40E22499564EAE7F71FA29AA19705F76%3Bjsessionid%3D787005E39F3AFF5E382EC41A340AB170%3Bjsessionid%3D31FD067A41084A84C97BE51309D7990D%3Bjsessionid%3D239C40B3727C3880B4DD59FDA993EB74%3Bjsessionid%3D12274BD3F00DF96945107322433EFB2D%3Bjsessionid%3DBABECBC0925C4C2EF20C533A8061A2D4%3Bjsessionid%3DA9667723F46F28605F09734A99CA4DA2%3Bjsessionid%3D6961CF836CF5728373E2183EADAB2533%3Bjsessionid%3D2895DFEDBF1325C8CD2C502532774450%3Bjsessionid%3D33C9460D4831AA6D3B7A709D82A8F842%3Bjsessionid%3D8D5BA59B60A1709E6B5F9C101B9EFDE3%3Bjsessionid%3D93580840AC4C429D04BD3F6F2436BB77%3Bjsessionid%3D73ED03EBAC438FBFCD9D44ACDC1CF6AE%3Bjsessionid%3DBB88F5D00D84261CFCDA4ED646098553%3Bjsessionid%3DE4F287F641347C3F3A57A0D97BA895FF